Seth Baum

Florida Atlantic University

Boca Raton, FL 33431

United States

SCHOLARLY PAPERS

1

DOWNLOADS

21

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (1)

1.

Resmetirom (MGL-3196) for the Treatment of Non-Alcoholic Steatohepatitis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial

Number of pages: 166 Posted: 19 Jul 2019
University of Oxford - Radcliffe Department of Medicine, Duke University, Duke University - Medical Center, Medpace, Duke University - Medical Center, University of California, San Diego (UCSD), University of Texas at San Antonio, Mount Sinai Health System - Icahn School of Medicine, Florida Atlantic University, Saint Louis University, Madrigal Pharmaceuticals and University of Arizona
Downloads 21 (516,814)

Abstract:

Loading...

MGL-319 resmetirom, NASH, non-alcoholic steatohepatitis, NAFLD, non-alcoholic fatty liver disease, lipids